Levodropropizine
From Wikipedia, the free encyclopedia
 |
|
|
Levodropropizine
|
|
| Systematic (IUPAC) name | |
| (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol | |
| Identifiers | |
| CAS number | |
| ATC code | R05 |
| PubChem | |
| Chemical data | |
| Formula | C13H20N2O2 |
| Mol. mass | 236.31 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Levodropropizine is a cough suppressant. It acts as a peripheral antitussive, with no action in the central nervous system and so does not cause side effects such as constipation or respiratory depression which can be produced by opioid antitussives such as codeine and its derivatives.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||
